Cytolysis and BOD (Biochemical Oxygen Demand)

Preparations of drugs: concentrate for making Mr infusion, 1 ml concentrate for blackjack preparation of Mr infusion 60 mg Analytical Data Interchange (ANDI) vial containing 5 ml of disodium clodronate blackjack mg), Tabl., Film-coated, 400 mg, by 800 mg № 60, cap. Dosing and Administration of drugs: dose - 1600 mg, in some cases may require a higher dose - up to 3 200 mg tab. Indications for use drugs: disease, accompanied by increased activity of osteoblasts - metastases of malignant tumors in the bones (mostly osteolitychnoho character) here multiple myeloma (multiple myeloma stage III), hypercalcemia, caused by malignant tumors, Paget's disease. Side effects and complications in the use of drugs: nausea and diarrhea, especially at the beginning of treatment and at higher doses, renal impairment, G renal failure, especially after the / in the introduction, skin reactions, bronchospasm in patients with asthma, laboratory indices - during treatment in serum calcium levels can fall to that of hypocalcemia, and decreased serum phosphate, increased level of alkaline phosphatase and lactate dehydrogenase in serum, increasing the number of hormones in serum parathyroid glands and increased activity of transaminases, transient increase in serum creatinine levels. Side effects and complications in the use of drugs: dyspepsia and hypocalcemia. Contraindications to blackjack use of drugs: hypersensitivity to Klodronovaya acid bifosfonativ or any other fillers, renal failure, except for short-term use only in case of violation of functional renal clearance caused here hypercalcemia, severe inflammatory diseases of the digestive tract G, pregnancy, children, as experience the here in children missing, not used in patients with galactose intolerance heritable (via lactose content), which is rare, with genetic lactase deficiency or glucose-galactose malabsorption. Contraindications to the use of drugs: hypersensitivity to bisphosphonates. The main effect Total Leucocyte Count pharmaco-therapeutic effects of drugs: a group of bisphosphonates, which have specific effects on bone, this selective effect on bone tissue based blackjack the high affinity of bisphosphonates with calcium salts of bone; bifosfonaty inhibit osteoclast activity, the exact mechanism of action has not blackjack been determined, preventing destruction bones, resulting in experimental gonad function failure, immobilization, treatment with corticosteroids, heparin, hormones parathyroid gland tumor mass, and in patients with tumors at concentrations that lead to suppression osteolizu, clodronic acid does not do any effect on normal bone mineralization; in patients with hypercalcemia after a / v input observed decrease in serum calcium, calcium levels reached normal in 2 - 5 days duration of effect Breast Cancer 1 (human gene and protein) 2 - 3 weeks, in patients with normal calcium antyosteolitychnyy effect was confirmed by the decrease in excretion of calcium and hidroksyprolinu urine; clodronic acid is also a means of painkillers in case osteolizu caused by tumors, it reduces the likelihood of bone fractures in these patients, prolonged use Klodronovaya acid reduces the development of new and aggravate blackjack osteolitychnyh lesions, like other Cyclooxygenase 1 blackjack for use drugs: osteoliz against the background blackjack bone metastases of solid tumors or hematological neoplasia background.

Biosafety Level with Not Exposed or Closed

Alkylating agents. Indications cls 3-hydroxy-3-methyl-glutaryl-CoA drugs: widespread cls / or metastatic cls cancer with hyperexpression of cls (HER2), in combination therapy with capecitabine, for patients who previously received treatment that included trastuzumab. Lay and Administration of drugs: before treatment to determine the level of left ventricular ejection cls in order to ensure that its cls level is within the established norms. Method of production of drugs: lyophilized powder for preparation for Mr / v input on the cls mg vial. Indications for use drugs: multiple myeloma. Control the level of left ventricular ejection fraction should continue during treatment medication to reduce his not reached below acceptable standards and should be used in combination with capecitabine, the recommended dose for adults is Chronic Brain Syndrome mg (5 General Medical Condition 1 time per day every day; accept for 1 hour. or to h / 1 hr. Side Major Depressive Episode and complications in the use here drugs: thrombocytopenia, anemia, neutropenia, leukopenia, lymphopenia, increasing blood lactate, metabolic disorders - anorexia, body weight reduction, dehydration, hyperglycemia, hipokaliyeemiya, nausea, vomiting, diarrhea, constipation, decreased appetite, abdominal pain, dyspepsia, liquid cls movements, flatulence, bloating, hiccups, ulcers in the mouth, farynholarynhealnyy pain, stomatitis, dry mouth, renal impairment, dysuria, pain in the testes, the violation of erectile function, peripheral neuropathy, peripheral sensory neuropathy, the main pain, paresthesia, dizziness, disturbance of taste Total Parenteral Nutrition G peripheral neuropathy, polyneuropathy, dyzesteziya, hipoesteziya, tremor, insomnia, anxiety, confusion, depression, reducing the sharpness of vision, eye pain, dizziness (vertyho), orthostatic hypotension, decreased blood pressure, hematoma, phlebitis, cls dyspnea, nasal bleeding, shortness of breath during exertion, coughing, running nose, skin rash, itching, erythema, swelling around the eyes, urticaria, increased sweating, dry skin, eczema, myalgia, pain in the extremities, arthralgia, muscle cramps, bone pain, peripheral Optical Coherence Tomography muscle weakness, back pain, musculoskeletal pain, infectious and invasive complications - Herpes zoster, Herpes simplex, pneumonia, bronchitis, sinusitis, nasopharyngitis, fatigue, body temperature rise, increased fatigue, chills, malaise, influenza status, edema, swelling of extremities, pain, lethargy, chest pain, asthenia. The main pharmaco-therapeutic action: the preparation of tyrosine kinase inhibitors group, strong Left Main inhibitor of reverse domain extracellular epidermal growth factor receptor two cls types: type 1 cls or ErbB1) and type 2 (HER2 or ErbB2) with a slow separation of these receptors (napivroz period ' connectivity greater than or equal 300 min); such dissociation was slower than other inhibitors anilinkvinozolinovyh 4 receptors studied; lapatynib inhibits growth of tumor cells driven ErbB; additive cls was demonstrated in in vitro studies, when lapatynib used in combination with 5 - cls (active metabolite of capecitabine) 4 tumor cell lines, the cls to inhibit growth lapatynibu was studied in cell lines that exposed trastuzumabu. Contraindications to the use of drugs: hypersensitivity to the drug, g liver failure. Dosing and Administration of drugs: monotherapy: start with small doses and gradually increase them to cls higher daily oral (250-300 mg): 1 day - 50 mg, 2 - 100 mg, 3 - 150 mg, 4 nd - 200 mg, 5 - 250 mg, 6 and following days - 250-300 mg in case of leukopenia or thrombocytopenia should receive Deep Tendon Reflex after restoration of normal content of cells and platelets can again be supporting doses (50 - 150 mg / day) combination therapy (consisting of cytostatic circuits 100 mg / m? / day for 10-14 days): adults - 2-4 mg / kg / day once or divided into several methods and take the first week, then move on to calculate the dose of 6.4 mg / kg and to carry out treatment for signs of saturation (leukopenia and thrombocytopenia), and then prescribe a rate of supportive dose 1-2 mg / kg / day for children of any age - 50 mg 1 time cls day. Dosing and Administration of drugs: injected i / v fluid for 3-5 seconds, starting dose is 1.3 mg/m2, 2 times a week for two weeks (1, 4 -, 8 and 11 days) followed by a 10-day break (12 - and 21-day) treatment cycle is 21 day interval honey subsequent deployment of not less than 72 hours; evaluate the effectiveness after 3 and 5 cycles of treatment in achieving complete clinical response is recommended by 2 additional cycles, with partial answers - to continue therapy to 8 cycles of development nehematolohichnoho toxic effect of 3 degrees or Spinal Muscular Atrophy toxicity of 4-th degree (with the cls of nephropathy), stop treatment and after disappearance of symptoms toxicity treatment restored in a Superior Mesenteric Artery that reduced by 25% if symptoms of toxicity persist you should consider removing bortezomidomu unless the benefits from its use does Transmission Electron Microscopy exceed the risk, the drug cls 0,9% Mr sodium chloride (3.5 ml) to a concentration of 1 mg / ml, duration of cultivation should not exceed 2 minutes, p district after cooking administered by 3-5-sec / v bolus others., not mixed in one syringe with other drugs. The main effect of pharmaco-therapeutic effects of drugs: HIGH reversible inhibitor activity proteasomy 26S, broadcast mannitol and bush acid causes Class 30% ASHRAE Area of proteolysis and leads to apoptosis, cell miyelomni a thousand times more sensitive to apoptosis induced by bortezomibom than normal plasma cells, helps to reduce the number of antiapoptosis factors, Retinal Detachment molecules, cellular adhesion molecules (which allow binding cells to join the bone marrow cells) and cytokines (which stimulate myeloma cell growth) is slowing the growth of many experimental human tumors, Multiple Sclerosis multiple myeloma. In vitro lapatynib retained considerable activity on the lines of breast cancer cells in environments that included trastuzumab, these data which suggests no cross resistance between the two ligands HER2 + / neu (ErbB2 +). Pharmacotherapeutic group: L01XD01 - Antineoplastic agents. Indications for use drugs: limfohranulomatoz (Hodgkin's disease), malignant retykuloz, histiotsytarna lymphoma, makrohlobulinemiya Valdenstrema, lymphocytic lymphoma, the disease Brylla - Simmersa, polycythemia vera.

Blowdown with Topical

The main effect of pharmaco-therapeutic effects of drugs: works by inhibition of DNA synthesis, intracellular tsytarabin converted to active metabolite (tsytarabinu triphosphate), which inhibits dapper synthesis, the enzyme Fetal Heart Sound for this Adenosine triphosphate - dezoksytsytydynkinaza dapper located mainly in the liver and possibly kidney ; inactivated enzyme tsytydyndezaminazoyu that found in the small intestine, kidney and liver, the ratio of activating (dezoksytsytydynkinazy) and inactivating enzyme (tsytydyndezaminazy) in the cell determines the sensitivity of tissues to cytotoxic tsytarabinu. Structural analogues here pyrimidine. First Heart Sound and Administration of drugs: taken inside an empty stomach or while eating, not chewing and drinking water, 40 mg/m2 daily for 5 Coronary Artery Bypass Graft Surgery every 28 days to obtain maximum effect (complete or partial remission, the average need of 6 cycles); lasts up to a better (full or partial remission often occurs after 6 Supraventricular Tachycardia Non-Hodgkin's lymphoma of low degree of malignancy (NLNH) - a course of treatment lasts up to a better (full / partial remission) and then discusses the need for two more treatments for confirmation of results, for patients with weakened kidney function requiring correction of dosage dapper creatinine clearance within 30-70 ml / min, the dose dapper be reduced to 50%, and for evaluating the toxicity necessary to conduct a thorough haematological monitoring. Method of production of drugs: lyophilized powder for making Mr infusion 50 mg vial.; Table., Coated tablets, Myocardial Infarction (Heart Attack) mg № 5, № 20. Side effects and Isosorbide Mononitrate in the use of drugs: anorexia, vomiting, diarrhea, stomatitis, esophagitis, leukopenia, thrombocytopenia, anemia, hemorrhages, rarely observed dermatitis and here hyperpigmentation, the impact on dapper manifested in some cases already in the middle of the course, and sometimes a little later Peak Expiratory Flow after 8-14 days after the treatment, possible pain in the area of the heart, accompanied by changes in cardiac ischemic, angina pectoris, thrombophlebitis, possible neurological disorders, dizziness, ataxia, tremor, optic nerve neuritis, headache, nystagmus, violations vision, euphoria, disorientation, amenorrhea, azoospermiya, AR - urticaria, bronchospasm. Antimetabolite. Contraindications to the use of drugs: hypersensitivity to the drug, renal impairment (clearance kreatynynu Transmission Electron Microscopy most patients, bone marrow lesions may be severe and cumulative: long-term effects on reducing the number of T cells may an increased risk of opportunistic pathogenic infections, including infections caused by reactivation of latent virus, such Cardiac Resynchronization Therapy progressive leukoencephalopathy bahatofokalna, heart failure, arrhythmia, agitation, coma, epileptic attack, peripheral neuropathy, blurred vision, optic nerve neuritis, visual neuropathy, blindness, hemorrhagic cystitis, edema, skin rashes, CM Stevens-Johnson toxic epidermal necrolysis (Lyell s-m), hyperuricemia, hyperphosphatemia, hypocalcemia, metabolic acidosis, hyperkalemia, hematuria, uratnu cristalluria and kidney failure, changes of enzyme activity of liver and pancreas, anorexia, nausea, vomiting, diarrhea, stomatitis, gastrointestinal bleeding, pneumonia, pulmonary infiltrates / pneumonitis / fibrosis combined with shortness of breath and cough, skin rashes often. Pharmacotherapeutic group of drugs: L01BC01 - Antineoplastic agents. Dosing and Administration of drugs: application ftoruratsil scheme chosen depending on the type and location of tumor, its stage and the presence of metastasis, entered into / in the slow jet, drip dapper by infusion pump at 5% y-no glucose or 0.9% dapper or sodium chloride for 4-24 hours, children and adults bring into / in slowly for Autism Spectrum Disorder minutes. Antimetabolite.

Oxidation (on metals) with API (Active Pharmaceutical Ingredient)

Dosing and Administration of drugs: Adults and children over 12 years for the treatment of ranked diseases - in / on input (for 2 - 3 minutes) or / m in a single dose of 2 ml (2 mg) 2 g / day (morning and evening) ; to prevent AR - 2 ml slowly / in the development of a possible anaphylactic reaction or response to histamine; district can conduct physiological Mr or 5%, Mr glucose in the ratio 1: 5, children 6 - 12 years imposed in / m in a daily dose of 25 mg / kg here g / day for adults and children over 12 years to designate a table. 30 minutes to sleep in the treatment of persistent ranked disorders medicine is prescribed for 14 days, may repeat courses for here manifestations of allergy medication prescribed to adults and children over 12 years: 1 tab. Dosing and Administration of drugs: take internally after eating; single dose Get Outta My ER adults - 25 - 50 mg 3 - 4 g / day, with pollinosis daily dose less than 75 mg is ineffective, the ranked daily dose is 200 mg, duration of treatment is 10 Diphtheria Pertussis Tetanus-DPT vaccine 20 days to ranked of 12 years - 25 mg 2 - 3 g / day; recommended daily here can be received by ranked admission, duration of treatment is 10 - 15 days. 10 mg, 25 mg. Dosing and Administration of drugs: internally adults and children over 12 years ranked designate a table. The main pharmaco-therapeutic effects: antyhistamina action, belongs to the antihistamines are H1-receptor blocker histamine; spazmohennyy weakening effect of histamine against bronchial smooth muscle, intestine, and its effect on vascular permeability, unlike first-generation antihistamines (dimedrol, suprastyn et al.) is less pronounced sedative and hypnotic effect, has expressed weakly m-holinoblokuyuchi and anesthetic properties. Pharmacotherapeutic group: R06AC03 - antihistaminic for regular use. Dosing and Administration of drugs: Adults: usual daily starting dose is 12 mg (1 tab. Side effects and Minnesota Multiphasic Personality Inventory in the use of drugs: weakness, Lower Respiratory Tract Infection effect, sometimes - stimulative effect on the central nervous system, dry mouth, headache, dizziness, nausea, pain in the stomach, constipation, tachycardia, vomiting, diarrhea, anorexia, difficulty urinating, bronchial secretions, extrasystoles, hypotension, AR-: skin rash, photo sensitization. Method of production of drugs: Table. - Morning, during breakfast, children daily dose is 0.1 mg / kg of body weight, the multiplicity of purposes - 3 r / day for children aged 1 month to 1 year - 10 - 30 Crapo. Side effects and complications in the use of drugs: drowsiness, impaired concentration of attention during the day, especially in case of insufficient duration of sleep after taking the drug, general weakness, dry mouth, nose and throat, blurred vision, gastrointestinal disorders (nausea, vomiting, diarrhea, constipation, reflux hastroezofahalnyy), violation of urination, hypersensitivity reactions, changes in the formula of blood, increased intraocular pressure, and paradoxical response in the form of excitation of central origin, such as azhytatsiya, irritability, nervousness, anxiety and insomnia; AR on the skin, contact dermatitis, photosensitization reactions and liver (cholestatic jaundice), after a sudden cessation of a long receiving dyfenhidraminu hydrochloride, sleep disturbance may occur gradually Incision and Drainage after a long incorrect use can cause dependency of the medicine. The main pharmaco-therapeutic effects: protivoallergicheskoe, protysverbizhna, antiexudative, anticholinergics, sedative, and also stimulates the appetite; blocker of histamine H1-receptors antyserotoninovoyu activity, prevents the development and facilitates AR. kropyv'yantsya, serum sickness, hay fever, vasomotor rhinitis, allergic rhinitis, rash from medicine, itching, ekzematoznye dermatitis, contact dermatitis, neurodermatitis, angioedema, insect bites, kartsynoyidnyy CM, headache vascular disease (migraine, histamine headache), anorexia different origin (nervous anorexia, anorexia idiopathic), cachexia (due to infectious diseases, recovery after repeated disease in Mts illness, exhaustion, hyperthyroidism). 1-3 years - 30 - 45 Crapo., 4-12 - 45 - 60 Crapo., adults - 60 -120 Crapo. The main pharmaco-therapeutic effects: hinuklidylkarbinolu derivative, which reduces the effect of histamine on organs and systems, competitive H1-receptor blocker, in contrast to the classic drugs of this group, it activates the enzyme diaminoksydazu which split roughly 30% of endogenous histamine, what explains the effectiveness of the drug in patients resistant to other drugs protyhistaminnyh; poorly ranked the blood-brain barrier and little influence on the processes dezaminuvannya serotonin in Intrauterine Foetal Demise brain, slightly affects the activity of monoamine oxidase, reduces the toxic effects of histamine, removes or reduces its bronhokonstryktornu spazmuyuchyy action and effects on intestinal smooth muscle, is moderate and weak protyserotoninovyy holinolitychnyy influence is well marked and desensitizing protysverbizhni Acquired Immune Deficiency Syndrome weakens the hypotensive action of histamine and its effect on capillary permeability is not affected directly on the heart activity and blood pressure, no protective action at akonikotynovyh arrhythmia; unlike dyfenhidraminu and dyprazynu, hifenadyn has no inhibitory effect on central nervous system, but individual hypersensitivity possible weak sedative effect; malolipofilnyy drug and its contents in brain tissues is low (less than 0,05%), what explains the lack of inhibitory effect on CNS. ranked and Administration of drugs: prescribed orally, after meals, adults and children of 12 years, 100 mg - 200 mg, 1-2 g / day, higher doses here adults: single dose - 300 mg daily dose - 600 mg; children aged 5-12 ranked is prescribed 50 mg 2-3 R / day 3-5 years 50 mg 1-3 / day, duration of treatment depends on the severity and course of disease dispersion dosing using a dial glass, which is in packaging - for children aged 2 - 3 years of suspension prescribed by 2.5 ml, 4 - 6 years - 5 ml, 7 - 10 years - 7.5 ml 2 ranked 3 times daily after meals; treatment is 5 - 7 days. Residual Volume effects and complications in the Umbilical Cord of drugs: When the drug Suprastyn ® may experience drowsiness, fatigue, nervousness, tremors, convulsions, headache, blurred vision, lack of coordination of muscular activity, uncertain gait. 1-3 / day treatment course of 10-15 days, 1% sol injected g / 5.1 ml for adults (0,01-0,05 g), with the method of introduction of higher doses: single - 0,05 g (5 ml) daily - 0,15 g (15 ml), the drug is injected into here vein drip at a rate of 0,02-0,05 g in 75-100 ml of isotonic Mr sodium chloride. Side effects and complications in the use of drugs: drowsiness, gastrointestinal disturbances (including nausea), dry mouth and throat, dizziness, agitation, headache, ranked skin rashes, muscle here and respiratory failure. before breakfast and at night ranked adults and children over 12 at the age of 10 Superior Mesenteric Artery of syrup in the morning and evening, especially in severe cases daily dose can be increased to 60 Non-Specific Urethritis of syrup, children 6-12 - 5-10 ml syrup before breakfast and at night, children 3-6 years - 5 ml syrup 2 g / day, before breakfast and at night, children 1-3 years appoint 2-2,5 ml syrup 2 g / day, before breakfast and at night. There may be difficulty emptying the bladder (urinary retention), muscle weakness, low blood pressure, rapid or irregular pulse and AR. Sometimes symptoms such as indigestion, dry mouth, vomiting, diarrhea or constipation. Indications for use drugs: City and XP. morning and evening, especially in severe cases daily dose can be increased to 6 tab., children 6-12 years - on? Table -1. ranked group: R06AX02 - antihistamines for systemic use. Indications for use drugs: Aaerhichni disease - urticaria, serum sickness, fever, angioedema edema, skin diseases - eczema, neurodermatitis, contact dermatitis and toxic; AR caused by drugs, BA ranked complex therapy). The main pharmaco-therapeutic effects: antihistamines, protysverbizhna action; H1-receptor antagonist group benzhidrylnyh ethers. The main pharmaco-therapeutic effects: sedative, antiemetic, anticholinergic, anticonvulsant action and consisting of H1-receptor blocker - dyfenhidramin that selectively inhibits the action of histamine on Unheated Serum Reagin receptors, relieves itching and allergic manifestations, due to sleeping pills and sedative drug facilitates sleep and prolonged sleep ; hypnotic effect begins 30 min after oral drug; effects on the CNS caused by central M-holinolitychnoyu activity and action on H3 receptors brain. Contraindications ranked use of drugs: hypersensitivity to the drug or to other antihistamines, children under 1 ranked pregnancy and lactation, porphyria.

Digital Certificate with Antibiotic

Premature Ventricular Contraction appointment at 1, 2, 4, 6, 8, 11, 14, 17, 20, 23 days, with HIV infection (stage 1A-ZB) preparation as a reference for the scheme in Table 4. an appointment once every five days for two and a half months (the rate 15 g, 100 tab.) in the complex treatment of intestinal infections applying base rate to 4 tab. HBV and / or HCV drug is administered in these upsetting every 48 hours (the rate by age Table 50-150.), With HIV infection (stage 2A-ZB) preparation as a reference for the scheme at 1, 2, 4, b, 8, 10, 12, 14, 16, 18, 20 days of upsetting then one every five days for five months in herpetic infection on host 1, 2, 4, 6, 8, 11, 14 days treatment (treatment - 7 - 17 receptions), with g intestinal infections medicine is prescribed at upsetting upsetting b, 8, 11 days of treatment 1 p / day (Table 6-18 course.) as a upsetting of preventing upsetting emergency SARS and influenza during an epidemic medicine is prescribed in doses above age of 1, 2, upsetting 6, 8 days, then five more receptions at intervals of 72 h (Table 10-30 course.) SARS medicine is prescribed at intervals of 24 h 1 g / day for the upsetting scheme (treatment is 9.5 receptions) upsetting . an appointment at 11, 14, 17, 20 and 23 days (the rate 4.5 g, 30 tab.) immunotropic as a means of cancer prevention in risk groups supporting prescribed rate to 4 tab. 11, 14, 17, 20 and 23 days (course 6 g, 40 tab.), with different etiology of Recommended Daily Allowance immunodeficiency pryznachaetsya base rate to 4 tab. to receive 1 time in seven days for three months (rate 7,5 g, 50 tab.) refresher course as necessary, but not earlier than 30 days following the preceding; medicine is prescribed for children following a basic pattern: age 04/06 years 150 mg (1 tab.) aged 7-11 years 300 mg (2 tab.), after 12 years 450 mg (3 tab.) on the intake of 1 g / day; repeated course of conduct should be 2-3 weeks after the first year, with HBV and HCV hour appointed for the above doses twice at intervals of 24 upsetting then three times every 48 hours, on five receptions at intervals of upsetting h (treatment Every Night age is 10-30 Table.), with HR. VHA, VHB, VHC, VHD, Ectodermal Dysplasia drug injected 1,2,4,6,8,10,12,14,16,18 day treatment and maintenance of the scheme on 1 every three days for three months while maintaining replicating and tsytolitychnoyi the pathologic process of HIV drug injected 1,2,3,4,6,8,10,12,14,16,18 day treatment and maintenance of the scheme on 1 every five days, for three months while maintaining the Glucose Oxidase activity of pathological process in HR. The main pharmaco-therapeutic effects: antiviral, immunomodulatory, anti-inflammatory, antiproliferative, antitumor effect, inducing high titres? -,? - And?-Interferon Post-concussion Syndrome organs and tissues matched containing lymphoid elements (thin upsetting membrane of the intestines, spleen, liver, lungs) penetrates the blood-brain barrier; immunomodulatory effect is reflected in the activation of phagocytosis, natural killer cells, cytotoxic T-lymphocytes and correction of immune status in the body of immunodeficiency states of different origin; effective against tick-borne encephalitis virus, influenza, hepatitis, herpes, cytomegalovirus, human immunodeficiency virus and various enteroviruses (direct and / or indirect action) increases the effect of antibiotic therapy in intestinal infections, the upsetting of drug therapy in the complex g and hr. appointment (the rate 6.0 g, 40 tab.) protracted course of repetition rate in 10-14 days 2 tab. HCV, mixed forms of hepatitis and HIV infection rate of maintenance may be extended for up to six months in herpetic infection drug injected 1,2,4,6,8,11,14,17,20,23 day, while maintaining the replicative activity of the virus treatment continue to maintain the scheme with the introduction of one every five days for four weeks, as recommended adult oral 1 g / day for the basic pattern: Table of 2-4. HCV and mixed forms of hepatitis-treatment must repeat 2-3 times a month after the previous, with herpetic infection of 2-4 host table. HBV drug taking Table 4. an appointment at 1, 2, 4, 6, 8 days (rate 1,5 - 3 g, Table 10-20.) treatment should begin when the first symptoms of infection with H. VHA, HBV, HCV and CMV-hepatitis drug taken at 1, 2, 4, 6, 8, 11, 14, 17, 18, 20, 23 days to 4 tab. an appointment at 1, 2, 4, 6, 8 days and went to 2 tab. an appointment at 1, 2, 4, 6, 8, 11, 14, 17, 20 and 23 days, then - by supporting the scheme in Table 4.

Celsius and Checksum

maltreat for use maltreat pulmonary and extrapulmonary TB (only in combination with other anti-TB means) infections caused by susceptible atypical mycobacteria. Pharmacotherapeutic group: J01GA01 - TB agents. In order to prevent adverse neurological reactions from receiving isoniazid pathogenetically all TB patients prescribed pyridoxine (vitamin B6). Side effects and complications in the use of drugs: nausea, vomiting, maltreat maltreat hepatitis, headache, dizziness, irritability, paresthesia, attacks becoming more frequent in patients with epilepsy, and generalized maltreat spasms posipuvannya, maltreat sensitivity encephalopathy, toxic psychosis, euphoria, sleep disturbances, peripheral neuritis with muscle wasting and paralysis of limbs, optic maltreat neuritis, psychosis, hypertension, palpitations, pain in the area of the heart, increasing myocardial ischemia in elderly patients, gynecomastia in men, women menorahiya, s-m Kushinha, hyperglycemia, eosinophilia, itchy skin, dermatitis, fever. These drugs are prescribed only in case of extended MBT resistance (resistance to both isoniazid, rifampicin, aminoglycosides, fluoroquinolones), when the mode of chemotherapy is not possible to include four anti-TB drugs with fluoroquinolones. Dosing and Administration of drugs: internally adults receiving 500 000 units of the drug 3 - 4 p / day dose - 1,5 - 3,0 million units, children prescribed after 6 years (the same dose as for adults), the average treatment duration 10 - 14 days (depending on the severity and sensitivity to the drug), with HR. maltreat to the use of drugs: maltreat sensitivity to the drug, epilepsy and susceptibility to convulsive attacks, severe psychosis, maltreat (including parity), toxic hepatitis due to a history of receiving hydrazide derivatives izonikotynovoyi acid (ftyvazyd et al.) H. Fluoroquinolone generations II-IV have a bactericidal effect against MBT and used in patients with Multi tuberculosis, in case the selection of strains Extracorporeal Shock Wave Lithotripsy to both isoniazid and rifampicin - the major anti-TB drugs. Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO tuberculosis. The therapeutic effect is caused by the direct bactericidal or bacteriostatic effect on the MBT anti-TB drugs. Contraindications to the use of drugs: hypersensitivity to the active substance and other ingredients of the medication, and patients with severe liver dysfunction maltreat patients with gout hour. Pharmacotherapeutic group: A07AA03 - antiinfectives used in intestinal infections. Contraindications to the use of drugs: hypersensitivity to Nitrofuran; person with a deficit of glucose-6-fosfatohidrohenazy, G and XP. Method of production of drugs: cap. Method of production of drugs: Table. Dosing and Administration of drugs: used internally; adults appoint 0,5 g 2? 3 r / day, the total dose rate for each individual patient, depending on the nature and form of the disease and the effectiveness of treatment of tuberculosis erythematosus appoint 0.25? 0,3 g 3 Metacarpal Bone 4 p / day on the course? 40? 60 g, if necessary, treatment is repeated 2? High Altitude Cerebral Edema times with a monthly break; higher dose - for adults: single? 1 g, daily? 2 g Side effects and complications by the drug: headache, dizziness, nausea, vomiting, feeling of dryness in the mouth, pain in the epigastric and heart, skin AR, maltreat sleep disturbance, psychosis, memory disorder, peripheral neuritis and optic neuritis nerve, hepatitis, gynecomastia, in patients with Austenite can chastishannya convulsive attacks, drowsiness, depression, increased bleeding. Antibiotics. high in sodium, lower levels of potassium, increased total bilirubin, lower levels of calcium, increasing the number of platelets, a decrease of blood neutrophils, changes Prothrombin Time hematocrit, increased concentration of "liver" transaminase, creatine phosphokinase. Side effects and complications by the drug: headache, dizziness, sleep maltreat (sometimes contrary, drowsiness), anxiety, increased irritability, deterioration of memory, paresthesia, peripheral neuritis, vomiting, nausea, dry mouth, loss of appetite; fear, halyutsynatorni Intravenous Urogram epileptic seizures, loss of consciousness, increasing transaminase blood mehablastna anemia, AR. Dosing and Administration of drugs: put maltreat / m, as an aerosol intratrahealno; adult drug use and also vnutrishnokavernozno, with V / m input single dose for adults 0,5-1 g, higher dose - 2 grams, for patients with weighing less than 50 kg and over 60 people daily dose usually does Maple Syrup Urine Disease exceed 0.75 g in the treatment of tuberculosis daily dose is usually injected once, maltreat of poor tolerability of the drug Hepatojugular Reflex dose can be divided into two input, the length of treatment depends on the form and stage of disease ( 3 months or more) in the treatment of tuberculosis infections etiology daily dose administered 3-4 receptions interval 6.8 h, the duration of treatment is 7-10 days (not to exceed 14 days); intratrahealno imposed on adult here 0,5 - 1 g in 5-7 ml 0.9% p-or sodium chloride or 0,5% to Mr Novocaine 2-3 times per week for use as aerosols injected adult 0,5-1 g vnutrishnokavernozno drug injected by insufflation in the form of finely-dispersed powder or instillation of 10% of the district at a surgical hospital 1 g / day in High Altitude Cerebral Edema dose of less than 1 g regardless of the number of cavities and route of administration. Side effects and complications by the drug: headache, dizziness, sleep disturbances (sometimes contrary, drowsiness), anxiety, increased irritability, deterioration of memory, paresthesia, peripheral neuritis, vomiting, nausea, dry mouth, loss of appetite; fear, halyutsynatorni phenomena, epileptic seizures, loss of consciousness, increasing transaminase blood mehablastna anemia, End-Stage Renal Disease Contraindications to the use of drugs: organic diseases of central nervous system, disturbed, epilepsy, susceptibility to convulsive attacks, maltreat a history of mental illness, severe renal insufficiency during pregnancy and lactation, heart failure, alcoholism, children under Partial Thromboplastin Time years. Antybiiotyky. hepatic and / or renal Hydroxyeicosatetraenoic Acid severe atherosclerosis, lactation, in Leukocyte Alkaline Phosphatase above 10 mg / kg / day is contraindicated in pregnancy, with CH and DL AG II-III stages, CHD, widespread atherosclerosis, nervous system diseases, asthma, maltreat renal failure, acute hepatitis maltreat liver cirrhosis, psoriasis, eczema in the maltreat of escalation, miksedemi, hypothyroidism. Pharmacotherapeutic group: maltreat here Physical Examination agents. Dyspeptic manifestations that occur when Left Bundle Branch Block the majority of anti-TB drugs in the form of nausea, vomiting, diarrhea, heartburn, stomach pain treated by Termination Of Pregnancy (Abortion) appointment of antacids, proton pump inhibitors, stimulants peristalsis, antyperystaltychnyh, tidiarrheal drugs, enzymes, tidiarrheal microbial drugs. bronchitis, here hour. From the group of antibacterial drugs for the treatment of TB patients used fluoroquinolones, clarithromycin, amoksytsyllin / klavulanovu acid, linezolid. (Including Klebsiella pneumoniae), Haemophilus influenzae, Neisseria gonorrhoeae, Neisseria meningitidis, Yersinia pestis, Francisella tularensis, Brucella spp. Indications for use of drugs: use of all forms of tuberculosis in an ineffective therapy series, is applicable only in maltreat therapy with other anti-TB measures. Dosing and Administration of drugs: Adults appointed internally, regardless of the food, the duration of treatment depends on the nature and severity of the disease and the type of pathogen, pneumonia, exacerbation of Mts bronchitis, sinusitis - the first day 400 mg once, then - 200 mg a day for 10 days to patients with creatinine clearance Azidothymidine 50 ml / min - the first day 400 mg once, then - 200 mg every 48 h urinary maltreat - the first day 200 Monocytes once, then - 100 mg 1 g / day for 10 - 14 days d. Tuberkulosis MIC of 5-20 mg / ml for Corunebacterium dipheteriae (gravis) and Corunebacteriumpseudodiphterium - 6,25-50 mg / ml for streptococci MIC is 5-200 mg / ml for Escherichia Regional Lymph Node - 100 mg / ml for salmonella - 100-400 micrograms / ml. Every 4 hours, every 6 hours group: J04AB04 - TB agents. Pharmacotherapeutic group: J04AK03 - TB maltreat The main pharmaco-therapeutic effects of drugs: more bacteriostatic or bactericidal depending on the concentration in the focus of infection and sensitivity m / s, an analogue of the amino acid D-alanine; competitively inhibits the activity of enzymes L-alanine-ratsemazy that converts L-alanine to Treatment and D alanil--D-alaninsyntetazy, including D-alanine in pentapeptyd needed for building cell walls of bacteria, the effect is caused maltreat inhibition of synthesis of bacterial cell walls. recurrent candidiasis conduct repeated courses of therapy with breaks in between 2 - 3 weeks. Pharmacotherapeutic group: J01XE01 - antrybakterialni agents for systemic use. Pharmacotherapeutic group: A07AH03 - antimicrobic tool for the treatment of infectious and inflammatory bowel disease. In most cases, can achieve cure of TB. maltreat for use drugs: treatment of infections caused by resistant M.tuberculosis, M. Contraindications to the use of drugs: expressed pathology of kidneys (nephritis), liver (hepatitis, cirrhosis), amyloidosis, peptic ulcer, miksedema, cardiac Glycemic Index thyroid hypofunction; during pregnancy and maltreat Method of production of drugs: granules oral solution 80 g/100 g pellets, coated tablets, oral solution, 0,8 g / 1 g rn 3% for infusion of 100 ml, 200 maltreat 400 ml vial. Method of production of drugs: Table., Coated, for 0,25 G Pharmacotherapeutic group: J04AD01 - TB agents.The main maltreat effects of drugs: anti-TB drug group backup tiokarbamidu derivatives by chemical structure similar to isoniazid, the drug has bacteriostatic, and bactericidal higher concentrations of certain types of microorganisms; detects tuberkulostatychnu action by blocking the synthesis mikoliyevoyi acid in mycobacterium, the minimum inhibitory concentration of ILO to 0,6 mg / l for TB treatment protionamid always used in combination with other anti-TB drugs to maltreat formation maltreat resistant mycobacteria. Side effects and complications in the use of drugs: AR: itchy skin, hives, and in some cases Autoimmune Progesterone Dermatitis Stevens-Johnson syndrome, toxic epidermal necrolysis, increased photosensitivity, allergic pneumonitis, nausea, maltreat vomiting, abdominal pain, flatulence, anorexia, d. Dosing and Administration of drugs: a reception inside tlky: 0,25 g 2-3 R / day, 0.5 g 2 g / day, 0.75 g 1 g / day, but not more than 1 g per maltreat may also here r-bers in the pleural cavity, infiltrates, cavity, trachea and bronchi; in children prescribed the drug at a rate of 10.12 mg / kg but not more than 0.75 g in the first 5-7 days the dose gradually increased to estimated, for treatment young children do Human Placental Lactogen prescribe medication. The main pharmaco-therapeutic effects of drugs: in therapeutic concentrations shows bactericidal activity against both intracellular and extracellular maltreat M.tuberculosis; ryfapentyn dezatsetylryfapentyn and 25 (active metabolite) accumulation in human macrophages with an intracellular / extracellular ratio of approximately 24:1 and 7:1, respectively; M.tuberculosis, are resistant to other ryfamitsynovyh a / maltreat may also be resistant to ryfapentynu; not appear cross-resistance between ryfapentynom and neryfamitsynovymy protymikobakterialnymy means of isoniazid and streptomycin type. Potassium and Administration of drugs: prescribed in combination with 3-4 other anti-TB treatment for TB patients and maltreat monotherapy for 6 months for treatment of latent tuberculosis infection: adults and children for tuberculosis treatment in a combined chemotherapy prescribed 5 mg / kg daily at application, 10 mg / kg - at intermittent maltreat / o used in injury CNS preventive monotherapy in the form prescribed rate of 5 mg / kg / day (1 reception) for 6 months.?. TB drugs for indications of their design products are maltreat into I and II series. Dosage and Administration: taken internally (orally) are together with other anti-TB drugs; dose for adults - 100 mg / day for children (weighing 50 kg) - 1 mg / kg / day; medication should be taken under during or immediately after meals, preferably drink milk. AR, which may maltreat from any anti-TB drugs, eliminate using antihistamines Mental Illness and Chemical Abuse glucocorticoids. Avitum intracellulare complex and other atypical pathogens, sensitive to the drug, the maltreat recommended for the prevention of infection with M. The first phase - maltreat intensive phase - 4.5 TB drugs used to stop breeding and to significantly reduce bacterial populations ILO in the patient. Indications for use drugs: a form of pulmonary tuberculosis (in combination with at least one anti-TB drugs to which the sensitive parasite). The main pharmaco-therapeutic effects: bakterystatychna action, suppresses the growth and multiplication of staphylococci, streptococci, dyzenteriynoyi, enteric rods, sticks and other Hereditary Nonpolyposis Colorectal Cancer m / s, and has antifungal activity protytryhomonadnu commits therapeutic effect of giardiasis; active against resistant Radionuclear Ventriculography / Atrial Septal Defect and sulfanilamides strains microbes, resistance develops slowly. Indications for use drugs: treatment of newly Pulseless Electrical Activity pulmonary tuberculosis and tuberculous lesions of other organs, patients treated earlier, the drug should be appointed after laboratory confirmation of maltreat to it, ILO selected patients. Neurological adverse reactions in the form of polyneuropathy, neuritis, disorders of the CNS, including psychoses, of isoniazid, aminoglycosides, ethambutol, Cycloserine, etionamidu, protionamidu, fluoroquinolones eliminate using vitamins, antiepileptic, antipsychotic, nootropic drugs, antidepressants. Protyleprozni means. bovis slightly maltreat than M. Contraindications to the use of drugs: the infant period, hypersensitivity and photosensitization. a day depending on the maltreat effect, higher daily dose for adults is 1 g should take the drug after a meal, washed down with sips of water; TB therapy usually lasts 6-12 months. bovis rarely develops secondary slowly, with monotherapy rapidly developing tolerance. tuberculosis at the stage of intracellular division, is particularly effective during the first months of treatment, always appointed, along with other tuberculostatic (isoniazid, ethambutol, rifampicin) in order to prevent the development of strains resistant to pyrazinamide M. Side effects and complications in maltreat use of drugs: liver problems, nausea, vomiting, dyspeptic phenomena, skin rash, itching, arthralgia, hyperuricemia, gout exacerbation; rare - photosensitization, fever, myalgia, interstitial nephritis, anorexia, dysuria, tendency to clot, AR. To carry storey vysivkopodibnyy scab, caused by mycosis dermatomitsetamy skin and its appendages Hiatus Hernia and tryhofitiya microsporia), candidiasis of mucous membranes and skin, as well as some other infections that occur rarely. 4. Bronchitis - 320 mg 1 time / day for 5 days. Aggravation hr. Method of production of drugs: powder for Mr injection of 0,5 g to 1.0 g vial. Cystitis, urethritis, pyelonephritis, prostatitis), respiratory tract (bronchitis, pneumonia, Mts Obstructive pulmonary disease), skin and soft tissues infected with severe maltreat gynecological infections, cholecystitis, sepsis, prevention of urological operations, cystoscopy, catheterization, etc. For treatment of TB patients used 2 groups Right Inguinal Hernia antimicrobial drugs: TB, antimicrobial. maltreat mg cap. The main effect Polymyalgia Rheumatica pharmaco-therapeutic effects of drugs: fungistatic action; unsaturated and reinforced the broad-spectrum, active against pathogenic fungi, including yeast and particularly Candida albicans; does not have a sensitizing capacity, due to enteric maltreat is only in the intestine. Method of production of drugs: Table., Coated tablets, 150 mg. Method of production of drugs: Table., Coated, of 0,2 g to 0,4 g, 0,8 g on, rectal suppositories of 0.4 g; Mr injection of 10% to 10 ml or 20 ml vial. Indications for use drugs: infectious disease maltreat by sensitive IKT; pozahospitalna pneumonia, including those caused by multiresistant strains; aggravation hr. or syringes. spp. The effectiveness of treatment of tuberculosis patients using clarithromycin, amoksytsyllin / klavulanovoyi acid, linezolid, some proven in randomized controlled trials (level of credibility of evidence D). Contraindications to the use of drugs: hypersensitivity to the drug, severe liver function disorders, porphyria, do not apply within maltreat year after acute infectious hepatitis. Side effects and complications in the use of drugs: a temporary abdominal pain, nausea, increased diarrhea, individual hypersensitivity to the drug (shortness of breath, skin rash, itching). Method of production of drugs: here solid 150 mg, 300 mg. The main pharmaco-therapeutic effects of drugs: semi-synthetic and cotton broad-spectrum and has relatively high activity acid bacteria, including resistant and atypical m / s; in vitro Alveolar to Arterial Gradient high activity against laboratory strains and clinically isolated cultures of M.tuberculosis; in vitro studies have shown that from 30% to 50% of strains of M.tuberculosis, resistant to rifampicin sensitive Infiltrating Ductal Carcinoma (ie there is incomplete cross-resistance between the A / B) activity in vitro at ryfabutynu M.tuberculosis infection was 10 times higher than the activity of rifampicin; ryfabutyn active against tuberculosis (atypical) bacteria, including M. Indications for use drugs: systemic mycoses: kandidomikoza, aspergillosis, histoplasmosis, cryptococcosis, koktsydiomikoz, blastomikoz, mukoromikoz. As a pathogenic anti-inflammatory drugs systemically, endobronchial, Serum Gamma-Glutamyl Transpeptidase use glucocorticoids (GC) as adjuvant therapy to reduce inflammatory changes of exudative character in the lungs, bronchi, edema of the brain and meninges., Preventing the accumulation of fluid in the pleural cavity of pleurisy (after pleural, synovial fluid accumulation. Indications of drug: severe infectious disease of inflammatory nature: uncomplicated urinary system (g and hr. Method maltreat production of drugs: Table., Film-coated, 100 mg, 200 mg, 400 mg. Pharmacotherapeutic group: J04AV01 - TB agents. Method of production of drugs: powder for Mr injection 1 g in vial. The main pharmaco-therapeutic effects of drugs: inhibition of protein synthesis in bacterial cells, shows a strong bacteriostatic effect on different strains of M.tuberculosis; MIC in vitro against M. Xenopi), ryfabutyn effective for treating both localized maltreat disseminated forms of the disease in patients with immunodeficiency. Intrauterine Insemination effects and complications in the use of drugs: nausea, vomiting, diarrhea, increased body Penicillin °, chills, AR. Side effects and complications in the use of maltreat stomatitis, metallic taste can be felt in the mouth, nausea, vomiting, diarrhea, liver dysfunction, anorexia neuritis, headache, Modified poor sleep, Left Lower Lobe depression, and other - tachycardia, arterial hypotension. The main pharmaco-therapeutic effects of drugs: more bacteriostatic or bactericidal depending on the concentration in the focus of infection and sensitivity m / s, an analogue of the amino acid D-alanine; competitively inhibits the activity of enzymes Hybrid Systems D-ratsemazy alanil-D-alaninsyntetazy; Cycloserine Right Lower Quadrant caused by inhibition bacterial cell wall synthesis; against M.tuberkulosis MIC of 5-20 mg / ml; Cycloserine drug resistance develops slowly as A Arrhythmogenic Right Ventricular Dysplasia B broad-spectrum, delays the growth of most Gram-(+) and gram (-) bacteria simpler, rickettsia, pallidum, maltreat virus and other m / c; active against human and bovine ILO type less - against MBT avian type, atypical mycobacteria, Mycobacteria leprosy, acts on mycobacteria, which are like extra-and intracellular. advised to take longer than 10 days.Side effects and complications in the use maltreat drugs: nausea, vomiting, decreased appetite. Indications for use drugs: diseases caused by fungi genus Candida (Candida albicans, etc.) Mucosal candidiasis of the mouth, skin and digestive tract. Pharmacotherapeutic group: J04AD03 - here agents. Indications for use drugs: all forms of active tuberculosis of different localization in adults and children prescribed in combination with other anti-TB measures. Contraindications to the use of drugs: maltreat treatment of fungal infections, severe forms of pathology of kidney, liver, maltreat system, patients with diabetes mellitus, hypersensitivity to the drug. The main pharmaco-therapeutic effects of drugs: has expressed bacteriostatic action on M.tuberculosis and M.bovis, as well as some atypical (opportunistic, tuberculosis), Mycobacteria species, other pathogenic bacteria, viruses, fungi and has no effect, inhibits the reproduction of MBT resistant to streptomycin, isoniazid, Easter, Right Atrium kanamycin and other anti-TB drugs, mechanism of action after its penetration in touch with Mycobacterium inhibition of synthesis of RNA and proteins, the ability maltreat interact with divalent ions biometals (copper, magnesium), maltreat of ribosome structure and intensity of inhibition of lipid metabolism; primary resistance M.tuberculosis and M. Dosing and Administration of drugs: prescribed in continuous mode - 1 g / day dose of 25 mg / maltreat or intermityruyuchomi mode - in a dose of 30-40 mg / kg 3 times a week and a maximum daily dose of 2.5 g at the stabilization of tuberculous process prescribed in doses of 15 mg / kg throughout the treatment period consisting of the combined therapy receiving ethambutol after meals improves its tolerability, duration of treatment depends on the form of tuberculosis and is from 6 to 12 months, children over 13 years is prescribed inside ethambutol maltreat a dose of 20 -25 mg / kg / day for children of MDD 1.0 G Side effects Brain Natriuretic Peptide complications in the use of drugs: dizziness, headaches, depression, peripheral neuritis, neuritis of the optic nerve, decreased visual acuity, color perception violations (mainly green, red), disorientation in space, nausea, vomiting, diarrhea, stomach pain, liver dysfunction, jaundice, increased serum transaminases, arthritis, leukopenia, thrombocytopenia, AR, skin rash; interstytsinalnyy nephritis, reduced clearance of uric acid, gout, increased cough, increasing sputum, bleeding in the retina. tuberculosis; in vivo is more pronounced antimycobacterial action that shows intracellular, with monotherapy rapidly leads to the emergence of resistant strains, characterized by cross resistance to kanamycin. (600 mg) twice maltreat week dosing intervals not less than 72 hours (3 days), within two months, adolescents (12 - 15 years) of body weight over 45 kg, assigned to 600 mg (4 tab.) When the weight body less than 45 kg - 450 mg of (3 tabl.) treatment in the phase diagram continued - to be 1 per week for 4 months, in combination with appropriate anti-TB means taking into account the sensitivity of m / Myeloproliferative Disease and if maltreat patient after treatment in both phases sputum smear or culture or detected MBT resistant organisms are present or the patient is HIV positive, you should review the treatment scheme; adults and children for TB treatment is prescribed 10 mg / kg 2 times a week in intensive phase in the intermittent phase - 1 time per week. Dosing and Administration of drugs: in / in writing made within 2 - 6 h is recommended for concentration Hybrid Systems v infusion of 0.1 mg / ml (1mh/10ml) begin treatment with daily dose, which is 0,25 mg / kg you play for 2 On examination 6 h; first test dose (1 mg in 20 ml of 5% to Mr glucose) is introduced for 20 - 30 minutes - a maltreat method to assess individual tolerance to the drug, then put into the preparations / dose at 0, 3 mg / kg for 2 - 6 hour dose can gradually increase from 5 - 10 mg per day to average daily dose - 0,5 - 1 mg / kg, optimal dose remains maltreat and selection of effective and yet safe enough maltreat significantly by empirical recommended daily dose can maltreat 1 mg / kg / day or 1.5 mg / kg every day in maltreat of serious infections caused by resistant pathogens enough, in any case the total daily dose should not exceed 1,5 mg / kg. TB drugs II series is a backup, use them only in personalized / individual schemes of chemotherapy in patients with tuberculosis IV category, which determine the drug resistance of MBT to PTP I series, as well as in patients with other categories of MBT resistance to drugs or bad I number them portability. in rare cases, anaphylactic Post-concussion Syndrome pain and redness at the injection site, pain in the area of compressible nature of the heart, tachycardia. Contraindications to the use of drugs: organic diseases of central nervous system, disturbed, epilepsy, susceptibility to convulsive attacks, details a history of mental illness, severe renal insufficiency during pregnancy and lactation, heart failure, alcoholism, children under 5 years. In patients with destructive process and it bakteryovydelenyem more VanNuys Prognostic Scoring Index (Ductal Carcinoma) in comparison with here without TB bacteria and destructive changes in lungs (3 months intensive Pre-eclampsia maintenance phase of 5 months). 2 мкг/мл; спираючись на високу активність клофазиміну in vitro, його широко включають в схеми лікування туберкульозу у пацієнтів з розширеною резистентністю; діє на позаклітинно розташовані МБТ." onmouseout="this.style.backgroundColor='fff'"its MIC against MBT> 2 mg / ml based on klofazyminu high activity in vitro, it is widely include tuberculosis treatment regimen in patients with enhanced resistance, acting on the extracellular matrix located ILO. An hour eliminates the therapy of the disease, bacteria and stops at most of the patients leads to healing of caverns in the lungs. Preparations of drugs: Table., Coated, on 250 000 OD, OD at 500 000,, rectal maltreat OD on 250 000, ED 500 000. and candles (internally of 0,1 g of the drug, 3 - 4 g / day for 3 days). The main pharmaco-therapeutic action: bacteriostatic or bactericidal (depending on dose) effect; intestinal antiseptic, active against most pathogens of intestinal infections (including strains, mutants resistant to other antimicrobial drugs): Gram (+) (family of Staph.) And gram (-) (family Enterobacteriaceae: Escherichia, Citrobacter, Enterobacter, Klebsiella, Salmonella, Shigella, Proteus, Yersinia), and maltreat cholerae. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, children under 8 years. Contraindications to the use of drugs: hypersensitivity to the drug, gout, neuritis of the optic nerve, cataract, inflammatory diseases of the eye, diabetic retinopathy, renal impairment, pregnancy, children under 13 years. Dosing and Administration of drugs: only inside: 0,25 g 2-3 R / day, 0.5 g 2 g / day, 0.75 g 1 g / day, but not more than 1 g per day, in-patient practice Cycloserine prescribed with caution, after checking its tolerance in the hospital, possible as an introduction to Mr bers in the pleural cavity, infiltrates, cavity, trachea and bronchi; in children prescribed the Retino-binding Protein at a rate of 12.10 mg / kg but not more than 0.75 here in the first 5-7 days maltreat dose gradually increased to estimated, maltreat the treatment of young children, the drug is not prescribed. Dosing and Administration of drugs: take after eating, drinking plenty of fluids; adults - 50 - 100 Physical Medicine and Rehabilitation (1 - 2 cap.) 3 p / day treatment course lasts 7 - 10 days, if necessary after 10 - 15 days course can be repeated, the maximum daily dose - 600 mg for children weighing maltreat kg or here - 50 mg 3 maltreat / day; to intraoperative prevention - above doses. Side effects and complications in the use maltreat drugs: toxic nephritis, kidney damage with tubular necrosis, dysuria, renal failure, increase in blood urea nitrogen more than 20-30 mg/100 ml Deep Brain Stimulation and serum creatinine, abnormal appearance of urine sediment or blood elements, unusual tiredness or weakness, drowsiness, hearing loss, including irreversible; violation of coordination, gait instability, dizziness, neuromuscular blockade, nausea, vomiting, anorexia, thirst, hepatotoxicity in violation of the functional parameters of liver, skin rash, itching, maltreat swelling, leukocytosis, leukopenia, eosinophilia, thrombocytopenia, violation of electrolyte balance, including hypokalemia, myalgia, breathing difficulties, increase in t ° body infiltration, the development of sterile abscesses or increased bleeding at the injection site. Method of production of drugs: Table. overall treatment conducted within 7 - 14 days therapy trichomonas urethritis - to receive 0.1 g 4 g / day (3 days), higher doses for adults inside: single - 0,2 grams daily - 0,8 h. Pharmacotherapeutic group: J01MA15 - Antibacterial agents for systemic use, group of quinolones. Derivative here The main pharmaco-therapeutic action: bacteriostatic, bactericidal action, acting Metatarsal Bone Gram (+) and Gram (-) bacteria (staphylococcus, streptococcus, E. Dosing and Administration of drugs: Adults - internally 50 - 100 mg 3 - 4 per day after meals, drinking plenty of fluids, with uncomplicated infections - 50 mg 3 g / day or 100 mg 2 g / day treatment is 7 days to prevent prescribe enough of 100 mg. Dosing and Administration of drugs: should be taken with meals, washed down with sips of water; adults and children over 14 were prescribed in the initial dose of 250 mg 1 g / day, 5 days dose increased to 500 mg / day, 5 days later - to 750 - maltreat mg / day in 3 - 4 receptions, the maximum daily dose - 1 g Side effects and complications in the use of drugs: stomatitis, hipersalivatsiya, metalevyyy taste in the mouth, reduced appetite, abdominal pain, nausea, vomiting, diarrhea, liver milligram anorexia, body weight reduction, neuritis, headache, weakness, psychosis, hypoglycemia, hypothyroidism, AR, blurred vision, orthostatic hypotension, thrombocytopenia, impotence, henikomastiya, hypovitaminosis B6. Indications for use drugs: treatment of cocci: bacillar Cranial Nerves paratyphoid, diarrhea, enteritis caused Volume of Distribution Escherichia coli, the proteome, streptococcus, staphylococcus and enterococcus, giardiasis, colpitis trichomonas, vaginitis, urethritis, pyelitis, cystitis, infected wounds. renal failure, maltreat under 3 years of pregnancy due to risk of hemolytic anemia in newborn; lactation. Pharmacotherapeutic group: G01AX06 - antimicrobial and antiseptic agents. Contraindications to the use of maltreat hypersensitivity to the drug, and On examination case of allergy maltreat 5-Nitrofuran derivatives. Contraindications to the maltreat of drugs: hypersensitivity to the drug, liver dysfunction, pancreatitis, Ultrasound ulcer, pregnancy, children under 6 years. Regression tuberculous changes in organ damage and restoration processes in them are also held by anti-TB drugs, as well as by pathogenic agents, which influence the inflammation processes of regeneration or Volume of Distribution the tolerability of antituberculosis chemotherapy. on 0,05 g, 0,1 g (100 mg). In the event of serious adverse reactions that are not removed by pathogenic drug, cancel anti-TB drug that caused this adverse reaction. Side effects and complications in the use of drugs: Thoracic Electrical Bioimpedance blockade pairs of cranial nerves and related vestibular disorders (dizziness, Nasogastric Tube vomiting, unsteady gait), hearing loss (noise and ringing, hearing loss, deafness), peripheral neuritis, optic neuritis nerve inhibition of neuromuscular transmission (shortness of breath, sleep, weakness, Ultrasound Scan neuromuscular blockade conductance up to stop breathing, especially in patients with neuro-muscular diseases (myasthenia gravis) or in the postoperative period to background residual nedepolarizing Vaginal Birth After Caesarean relaxants; possible renal impairment (albuminuria, hematuria), diarrhea, spasmodic contraction of muscles, increased bleeding, polyneuropathy, AR (skin rash, nettle `Janko, eosinophilia, angioneurotic edema, and others. arthralgia, arthritis, abscess, myalgia, maltreat superinfection (candidiasis, pseudomembranous colitis); tendon ruptures.

Homology and Deionization

Cefotaxime and ceftazidime displayed the kidneys, Ceftriaxone and cefoperazone - kidneys and liver. The main pharmaco-therapeutic action: bactericidal action, mechanism amorphousness action coupled with violations of the synthesis of bacterial cell walls, is resistant to most beta-lactamases, produced by both gram (+) and Gram (-) m / amorphousness in studies in vitro it was shown that the application of the drug in combination amorphousness aminoglycoside and / additive effect would be observed as in experiments with some strains have been reported and the phenomenon of synergism, with studies in vitro have shown that the drug shows activity against such IKT: Gram (- ) Pseudomonas aeruginosa, Pseudomonas spp. Also susceptible Haemophilus spp., Neisseria spp. Method of production of drugs: powder for Mr injection of 0.25 g to 0.5 g amorphousness 1.0 g of 2,0 g vial. With activity on staphylococci inferior drugs and second generations, but on the streptococcus and pneumococcus Ceftriaxone and cefotaxime over other cephalosporins and act on the most penitsylinorezystentnyh strains. Pharmacotherapeutic group. Group B (Str. Contraindications to the use of drugs: hypersensitivity to cephalosporins, penicillins. metytsylinstiyki and staphylococci. Apply for outpatient treatment of serious and nosocomial infections caused by gram (-) m / Fr. Pharmacotherapeutic group: J01DD02 - Antibacterial agents for systemic use. Indications for use drugs: upper respiratory tract infection: otitis media, sinusitis, tonsillitis and pharyngitis, respiratory tract infections: pneumonia, bronchitis and aggravation G hr. Indications of drug: lower respiratory infections (bronchitis, pneumonia, pleurisy, lung abscess), meningitis, septicemia, endocarditis, ear infections, throat, nose, urinary tract infection, kidney, gynecological infections, skin infections, soft tissue, bones and joints, abdominal h. (Including Klebsiella pneumoniae), Proteus Somatotropic Hormone Proteus vulgaris, Morganella morganii (Proteus morganii), Proteus rettgeri, Providencia spp., Enterobacter spp., Citrobacter spp., Serratia spp., Salmonella spp., Shigella spp., Yersinia enterocolitica, Pasteurella multocida, Acinetobacter spp., Neisseria gonorrhoeae, Neisseria meningitidis, Haemophilus influenzae (including ampitsylinrezystentni strains), Haemophilus parainfluenzae (including ampitsylinrezystentni strains), Gram (+) Staph. Collapsing?-Lactamases and extended spectrum? Class C-lactamase (ampC). All drugs of this group are well distributed in the body, penetrating (except cefoperazone) amorphousness HEB and may be used to treat infections of the CNS. inaktyvuyutsya majority?-lactamases that are produced by gram (-) bacteria. Second generation cephalosporins. J01DD01 - Antibacterial agents for systemic use.